RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biotechnology Assets Stock

Biotechnology Assets ROA 2024

Biotechnology Assets ROA

0.09

Ticker

BST.MC

ISIN

ES0184980003

WKN

A1XB95

In 2024, Biotechnology Assets's return on assets (ROA) was 0.09, a -190.22% increase from the -0.11 ROA in the previous year.

Biotechnology Assets Aktienanalyse

What does Biotechnology Assets do?

ADL Bionatur Solutions SA is a Swiss company specializing in the development and production of natural ingredients for the food, cosmetics, and pharmaceutical industries. The company was founded in 2000 and has since had an impressive success story. ADL Bionatur Solutions SA's business model is based on the use of plants and microorganisms to extract high-quality natural active ingredients. The company employs environmentally friendly methods and sustainable production practices that meet the needs of society and nature alike. One of ADL Bionatur Solutions SA's main sectors is the production of natural flavors and colorants for the food industry. Depending on customer preferences, color pigments are extracted from fruits, vegetables, or other plants to color food products with natural ingredients. Natural flavors are also isolated using plant extracts and other natural sources. These products are particularly sought after because they are not only healthier than synthetic alternatives but also provide consumers with a better feeling. Another significant sector of ADL Bionatur Solutions SA is the development of cosmetics based on natural ingredients. For example, extracts from algae, flowers, or herbs are used to create skincare products that are gentle on the skin while still being highly effective. Products targeting signs of aging or acne are also based on natural ingredients from ADL Bionatur Solutions SA. In addition to these two main sectors, ADL Bionatur Solutions SA also offers products for the pharmaceutical industry. The company focuses on developing active ingredients based on natural substances that can be used to treat various diseases. Sustainability is also a key focus here, as naturally derived active ingredients are not only healthier but also have a higher biological availability. In addition to these main sectors, ADL Bionatur Solutions SA provides consulting services to customers. This includes the development of tailored natural solutions and support for product certification according to the highest international standards. Overall, in recent years, ADL Bionatur Solutions SA has become one of the world's leading companies in the field of natural ingredients. With a wide portfolio of products and services and a strong focus on sustainability and environmental compatibility, the company is well-positioned to benefit from the ongoing trend towards natural and healthier products. Biotechnology Assets ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Biotechnology Assets's Return on Assets (ROA)

Biotechnology Assets's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Biotechnology Assets's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Biotechnology Assets's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Biotechnology Assets’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Biotechnology Assets stock

What is the Return on Assets (ROA) of Biotechnology Assets this year?

The Return on Assets (ROA) of Biotechnology Assets is 0.09 undefined this year.

What was the ROA of Biotechnology Assets compared to the previous year?

The ROA of Biotechnology Assets has increased by -190.22% compared to the previous year.

What consequences do high ROA have for investors of Biotechnology Assets?

A high ROA is advantageous for investors of Biotechnology Assets, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Biotechnology Assets?

A low ROA can be unfavorable for investors of Biotechnology Assets as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Biotechnology Assets affect the company?

An increase in ROA of Biotechnology Assets can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Biotechnology Assets impact the company?

A reduction in the ROA of Biotechnology Assets can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Biotechnology Assets?

Some factors that can influence the ROA of Biotechnology Assets include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Biotechnology Assets important for investors?

The ROA of Biotechnology Assets is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Biotechnology Assets take to improve ROA?

To improve ROA, Biotechnology Assets can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Biotechnology Assets pay?

Over the past 12 months, Biotechnology Assets paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biotechnology Assets is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biotechnology Assets?

The current dividend yield of Biotechnology Assets is .

When does Biotechnology Assets pay dividends?

Biotechnology Assets pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biotechnology Assets?

Biotechnology Assets paid dividends every year for the past 0 years.

What is the dividend of Biotechnology Assets?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biotechnology Assets located?

Biotechnology Assets is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biotechnology Assets kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biotechnology Assets from 10/1/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Biotechnology Assets pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Biotechnology Assets in the year 2023?

In the year 2023, Biotechnology Assets distributed 0 EUR as dividends.

In which currency does Biotechnology Assets pay out the dividend?

The dividends of Biotechnology Assets are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biotechnology Assets

Our stock analysis for Biotechnology Assets Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biotechnology Assets Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.